This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Peter Eriksson - Innovator in Neuroprotection
Introduction
Peter Eriksson is a notable inventor based in Sweden, recognized for his contributions to the field of neuroprotection. His innovative work focuses on the use of antisecretory factors to enhance the recovery of injured or diseased nervous tissue. Although he currently holds no patents, his research has significant implications for treating conditions associated with cell loss or gain.
Latest Patents
Peter Eriksson's most recent patent is titled "Use Of Antisecretory Factor For Neuroprotection." This invention relates to the application of an antisecretory protein or its homologues, which possess properties beneficial for the manufacture of medicaments or medical foods. The invention aims to improve the rescue of injured or diseased nervous tissue, as well as to promote the proliferation, apoptosis, differentiation, and migration of various stem cells. A preferred embodiment of this invention addresses conditions such as neurotrauma and diseases of the central nervous system (CNS), peripheral nervous system (PNS), and autonomic nervous system (ANS), including Alzheimer's disease.
Career Highlights
Peter Eriksson is currently employed at As Faktor AB, where he continues to develop his innovative ideas and research. His work is characterized by a strong commitment to advancing medical science and improving patient outcomes through novel therapeutic approaches.
Collaborations
Peter collaborates with esteemed colleagues such as Hans-Arne Hansson and Eva Jennische, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Peter Eriksson is a dedicated inventor whose work in neuroprotection holds promise for the future of medical treatments. His research efforts aim to address critical challenges in the field of neuroscience, potentially leading to breakthroughs in the management of neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile